In: Journal of Antimicrobial Chemotherapy, ///-
|
In: Journal of Antimicrobial Chemotherapy, ///-
|
|
|
In: Journal of Antimicrobial Chemotherapy, ///-
|
In: Lasers in Medical Science, 2015, vol. 30, no. 3, p. 1147-1151
|
In: European Journal of Clinical Microbiology & Infectious Diseases, 2015, vol. 34, no. 10, p. 1937-1945
|
In: Journal of Antimicrobial Chemotherapy, 2016, vol. 71, no. 1, p. 156-161
|
In: World Journal of Urology, 2015, vol. 33, no. 4, p. 531-537
|
In: International Journal of Antimicrobial Agents, 2020, vol. 56, no. 6, p. 106157
Background: Carbapenemase-producing Gram-negative bacteria cause infections that are difficult to treat and represent a rising threat to healthcare systems worldwide. This study analysed isolates of Escherichia coli (E. coli), a species associated with nosocomial-acquired and community-acquired infections, from hospitals in Germany and Switzerland exhibiting a slight decrease in...
|
In: Journal of Clinical Microbiology, 2020, p. -
A series of clinical NDM-5-producing E. coli isolates obtained from two surveillance networks of carbapenem-producing Enterobacterales from 2018-2019, namely Switzerland (NARA) and Germany (SurvCARE), were analyzed. The 33 NDM-5- producing E. coli isolates were highly resistant to β-lactams including the novel ß- lactam/ß-lactamase inhibitor combinations (ceftazidime/avibactam, ...
|